Skip to content

Clinical trials

Phase 1 Lupus Nephritis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Nephritis Phase: Phase 1 Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20141
20191
20231
20246
20259
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Active, not recruiting5
Completed4
Withdrawn3
Enrolling by invitation3
Not yet recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital for Special Surgery, New York2
Takeda2
Adicet Therapeutics1
Allogene Therapeutics1
Artiva Biotherapeutics, Inc.1
Atara Biotherapeutics1
Biocon Limited1
Bristol-Myers Squibb1
CRISPR Therapeutics1
Century Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Nephritis26
Lupus Erythematosus, Systemic21
Scleroderma, Systemic12
Myositis9
Autoimmune Diseases8
Scleroderma, Diffuse7
Dermatomyositis5
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis4
Arthritis, Rheumatoid3
Polymyositis2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.